Coronary Artery Disease News and Research RSS Feed - Coronary Artery Disease News and Research

Coronary artery disease is the most common type of heart disease and the leading cause of death worldwide. It occurs when the arteries that supply blood to the heart become narrowed or blocked by a buildup of "plaque" - cholesterol or other fatty deposits that build on the inner wall of the artery. Over time, this plaque build up results in a reduction of blood flow to the heart, which can cause chest pain. If the artery becomes completely blocked, usually by a blood clot, oxygen is prevented from reaching the heart which can result in a heart attack and/or damage to the heart tissue.
Fasting converts bad cholesterol in fat cells to energy, combating diabetes risk factors

Fasting converts bad cholesterol in fat cells to energy, combating diabetes risk factors

For prediabetics, many interventions focus on lifestyle changes and weight loss, but new research on periodic fasting has identified a biological process in the body that converts bad cholesterol in fat cells to energy, thus combating diabetes risk factors. [More]
Study shows significantly increased risk of heart attack in patients with Sj-gren's syndrome

Study shows significantly increased risk of heart attack in patients with Sj-gren's syndrome

A new study presented today at the European League Against Rheumatism Annual Congress (EULAR 2014) showed a significantly increased risk of heart attack in patients with Sj-gren's syndrome (SjS), particularly in the first year following diagnosis. [More]
Study supports proposal to screen all men with gout for presence of ED

Study supports proposal to screen all men with gout for presence of ED

A new study presented today at the European League Against Rheumatism Annual Congress showed that erectile dysfunction (ED) is present in most men with gout and is frequently severe. [More]
Risk factors for hospital readmissions identified in stroke patients

Risk factors for hospital readmissions identified in stroke patients

Hospital readmission, an important measure of quality care, costs the United States an estimated $17 billion each year. And according to the Centers for Medicare and Medicaid Services, about half of those readmissions could be avoided. [More]
Advances in understanding of genetics of CAD lead to more therapeutic targets

Advances in understanding of genetics of CAD lead to more therapeutic targets

Advances in the understanding of the genetics of coronary artery disease, or CAD, will revitalize the field and lead to more therapeutic targets for new medicines to combat this common disease, suggests a genetics expert from the Perelman School of Medicine at the University of Pennsylvania in a Perspective article in the new issue of Science Translational Medicine. [More]
Non-obstructive coronary artery disease linked with 28 to 44% increased risk of major heart attack

Non-obstructive coronary artery disease linked with 28 to 44% increased risk of major heart attack

Non-obstructive coronary artery disease was associated with a 28 to 44 percent increased risk of a major adverse cardiac event such as a heart attack or death, in a new study presented at the American Heart Association's Quality of Care and Outcomes Research 2014 Scientific Sessions. [More]
STENTYS signs agreement to acquire assets of Cappella Peel Away

STENTYS signs agreement to acquire assets of Cappella Peel Away

STENTYS, a medical technology company commercializing in Europe the world's first and only Self-Apposing® Stent to treat acute myocardial infarction (AMI), today announced the signing of the acquisition agreement of Cappella Peel Away Inc. (Delaware, USA) and its assets relating to a novel stent delivery system. The acquisition is subject to closing conditions. [More]
NYU Langone scientists identify promising treatment target for Alzheimer's disease

NYU Langone scientists identify promising treatment target for Alzheimer's disease

Scientists at NYU Langone Medical Center have identified a compound, called 2-PMAP, in animal studies that reduced by more than half levels of amyloid proteins in the brain associated with Alzheimer's disease. [More]
Mount Sinai Heart to host four-day symposium on Complex Coronary, Valvular, and Vascular Cases

Mount Sinai Heart to host four-day symposium on Complex Coronary, Valvular, and Vascular Cases

Mount Sinai Heart will host its innovative and prestigious 17th Annual 2014 Live Symposium of Complex Coronary, Valvular, and Vascular Cases June 10-13 at The Mount Sinai Hospital. [More]
Blood gene expression profile identifies patients with elevated risk of cardiovascular death

Blood gene expression profile identifies patients with elevated risk of cardiovascular death

A study of 338 patients with coronary artery disease has identified a gene expression profile associated with an elevated risk of cardiovascular death. Used with other indicators such as biochemical markers and family history, the profile - based on a simple blood test - may help identify patients who could benefit from personalized treatment and counseling designed to address risk factors. [More]
Micell Technologies presents DESSOLVE I and II trial data at EuroPCR conference

Micell Technologies presents DESSOLVE I and II trial data at EuroPCR conference

Micell Technologies, Inc. today announced that long-term clinical outcomes from its DESSOLVE I and II clinical trials were presented at the EuroPCR conference in Paris, France this week. [More]
Study looks at stem cells to pinpoint how excess fat is stored

Study looks at stem cells to pinpoint how excess fat is stored

With three million people dying worldwide each year as a direct result of being overweight or obese, a new study will look at stem cells to pinpoint how excess fat is stored - potentially paving the way for new treatments to combat killer diseases associated with obesity. [More]
Endo acquires worldwide rights to Zogenix' sumatriptan injection

Endo acquires worldwide rights to Zogenix' sumatriptan injection

Endo International plc announced today that affiliates of the company have completed the acquisition of worldwide rights to Sumavel® DosePro® (sumatriptan injection), a needle-free delivery system for subcutaneous use, from Zogenix, Inc, for $85 million in cash and rights to additional cash payments based on the achievement of certain commercial milestones. [More]

Abbott's vascular devices manufacturing facility receives Shingo Prize

Abbott has been awarded the Shingo Prize, an international award for operational excellence, by the Shingo Institute at the Jon M. Huntsman School of Business at Utah State University. Abbott's vascular devices manufacturing facility in Clonmel, Ireland, received the award, recognizing the site's initiative to develop and maintain continuous improvement to achieve operational excellence. [More]
Power of GWAS to detect human disease can be increased using statistical testing

Power of GWAS to detect human disease can be increased using statistical testing

The power of genome-wide association studies (GWAS) to detect genetic influences on human disease can be substantially increased using a statistical testing framework reported in the May issue of the journal GENETICS. [More]
GEN Publishing introduces semi-monthly digital publication focusing on OMICs technologies

GEN Publishing introduces semi-monthly digital publication focusing on OMICs technologies

GEN Publishing recently introduced Clinical OMICs a semi-monthly digital publication focusing on the application of OMICs technologies in clinical settings. These advanced techniques, such as next-gen sequencing, are beginning to transform medical care just as they revolutionized basic life science research over the past decade-and-a-half. [More]
New study sheds light on mysterious gene that influences cardiovascular health

New study sheds light on mysterious gene that influences cardiovascular health

A new study from researchers at the University of Ottawa Heart Institute (UOHI), published today in Cell Reports, sheds light on a mysterious gene that likely influences cardiovascular health. [More]
Oral health: The gateway to your overall health

Oral health: The gateway to your overall health

If the eyes are the windows to your soul, then your mouth is the gateway to your overall health. Research has found a surprising number of links between the state of your oral health and your overall health. [More]
Early identification of heart disease a priority for schizophrenia patients

Early identification of heart disease a priority for schizophrenia patients

Early recognition and treatment of coronary artery disease must become a clinical priority for all adults with schizophrenia, say researchers who studied autopsy data for schizophrenia patients who died suddenly in hospital. [More]
Health clinics can ease financial burden on hospitals and insurance companies

Health clinics can ease financial burden on hospitals and insurance companies

Health clinics that can provide primary care for low-income patients may ease the financial burden on both hospitals and insurance companies while improving patient health, researchers have concluded. [More]